Zhengbo Song (Zhongbo Song)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Combination Therapy

Peritoneal Dialysis

Tyrosine Kinase

Ejection Fraction

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Clinical cancer research : an official journal of the American Association for Cancer Research

Medical oncology (Northwood, London, England)

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Han Si, Xiaoshuang Fu, Yue Hao, Yina Wang, Gen Lin, Dong Wang, Chunwei Xu, Yongchang Zhang, Zhengbo Song
The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Keda Shao, Xiaohong Zeng, Yue Hao, Yanhua Wang, Chunwei Xu, Zhengbo Song
Rechallenge immunotherapy after immune resistance in patients with advanced thymic carcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Lan-Lan Pang, Yi-Hua Huang, Weitao Zhuang, Yaxiong Zhang, Jun Liao, Yue Hao, Feng Hao, Guoqian Wang, Ze-Xin Chase Chen, Yu Zhu, Mengzhen Li, Zhengbo Song, Bo Peng Deng, Jing Li, Li Zhang, Wenfeng Fang
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (12) (2024)
Lan-Lan Pang, Yi-Hua Huang, Weitao Zhuang, Yaxiong Zhang, Jun Liao, Yue Hao, Feng Hao, Guoqian Wang, Ze-Xin Chase Chen, Yu Zhu, Mengzhen Li, Zhengbo Song, Bo Peng Deng, Jing Li, Li Zhang, Wenfeng Fang
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (12) (2024)
Yanhua Wang, Jingwen Wei, Manyi Xu, Jing Xiang, Keda Shao, Yue Hao, Zhengbo Song
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Ke Wang, Manyi Xu, Yanhua Wang, Chunwei Xu, Yue Hao, Zhengbo Song
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Lan-Lan Pang, Yi-Hua Huang, Weitao Zhuang, Yaxiong Zhang, Jun Liao, Yue Hao, Feng Hao, Guoqian Wang, Ze-Xin Chase Chen, Yu Zhu, Mengzhen Li, Zhengbo Song, Bo Peng Deng, Jing Li, Li Zhang, Wenfeng Fang
Co-occurring EGFR p.E709X mutation Mediates Primary Resistance to the Third-generation EGFR-TKIs in EGFR p.G719X-mutant Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yelan Guan, Qifeng Yao, Yue Hao, Xiaohong Zeng, Wen-Xian Wang, Xiadong Gu, Jing Xiang, Yan Sun, Zhengbo Song
The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis. Cancer medicine (2023)
Manyi Xu, Yue Hao, Huan Zhou, Zheng Shi, Jinfei Si, Zhengbo Song
Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study. Medical oncology (Northwood, London, England) 40 (7) (2023)
Jingwen Wei, Zheng Shi, Zhengbo Song
Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non-small cell lung cancer: A real-world study. Cancer medicine (2023)
Yue Hao, Manyi Xu, Huan Zhou, Jinfei Si, Yu Fang, Chunwei Xu, Zhengbo Song
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709X. Medical oncology (Northwood, London, England) 40 (1) (2022)